Schenkein David P 4

4 · Denali Therapeutics Inc. · Filed Jun 5, 2026

AI-generated summary of this filing

Updated Jun 5, 2026

Denali Therapeutics (DNLI) Director David Schenkein Receives Award

What Happened

David P. Schenkein, a director of Denali Therapeutics (DNLI), received equity awards on 2026-06-03: 6,408 restricted stock units (RSUs) and 19,226 derivative RSU-type awards. The Form 4 reports $0 as the transaction price/value (these were compensatory awards, not open-market purchases).

Key Details

Transaction date: June 3, 2026; Form 4 filed June 5, 2026 (timely filing).
Reported price/value: $0 for both items (standard for many RSU/derivative grants on Form 4).
Shares owned after transaction: Not specified in the provided filing excerpt.
Vesting: Footnotes state 100% of the RSUs (and shares subject to an option, where applicable) vest upon the earlier of (i) one year after the grant or (ii) the day before the issuer’s next annual meeting of stockholders.
Trust holdings: Some shares are held of record by the David P. Schenkein 2004 Revocable Trust and the Amy P. Schenkein 2004 Revocable Trust (he and his spouse serve as trustees) — these reflect record ownership reported on the form.
No 10b5-1 plan, tax-withholding sale, or late-filing indication provided in the excerpt.

Context

These are compensatory awards (RSUs/contingent rights) that do not represent immediately tradable shares. They convert to common stock only upon vesting according to the schedule noted above. Such awards are routine for directors and reflect compensation rather than an open-market purchase or sale.

Form 4

Period: 2026-06-03

Director

Transactions

Award
Common Stock
[F1][F2]
2026-06-03+6,408→ 21,665 total
Award
Stock Option (right to buy)
[F5]
2026-06-03+19,226→ 19,226 total
Exercise: $19.66Exp: 2036-06-03→ Common Stock (19,226 underlying)

Holdings

Footnotes (5)

[F1]Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.
[F2]Includes 6,408 unvested RSUs.
[F3]The shares are held of record by the David P. Schenkein 2004 Revocable Trust, for which the Reporting Person serves as a trustee.
[F4]The shares are held of record by the Amy P. Schenkein 2004 Revocable Trust, for which the Reporting Person's spouse serves as a trustee.
[F5]100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.

Signature

/s/ Tyler Nielsen, by power of attorney|2026-06-05

1 file